Calamos Wealth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$4.38M |
| 2 |
T-Mobile US
TMUS
|
+$4.21M |
| 3 |
Salesforce
CRM
|
+$3.93M |
| 4 |
IQVIA
IQV
|
+$2.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$2.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$5.75M |
| 2 |
Broadcom
AVGO
|
+$5.46M |
| 3 |
Apple
AAPL
|
+$5.28M |
| 4 |
Mastercard
MA
|
+$4.21M |
| 5 |
Eli Lilly
LLY
|
+$4.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Consumer Discretionary | 12.54% |
| 3 | Financials | 10.69% |
| 4 | Healthcare | 8.49% |
| 5 | Communication Services | 7.33% |
Similar funds
Calamos Wealth Management's Q3 2021 Portfolio in Review
As of Q3 2021, Calamos Wealth Management held 323 positions worth $1.24B, down 3.6% from $1.28B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Calamos Wealth Management withdrew a net $60.5M in Q3 2021, closing 14 positions and reducing 116 holdings. Its most notable exit was Exact Sciences, an estimated $3.61M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Calamos Wealth Management opened a new position in Jazz Pharmaceuticals worth $3.78M.
- Calamos Wealth Management's largest Q3 2021 buy was Jazz Pharmaceuticals: 29,003 shares worth $3.78M.
- Calamos Wealth Management added most to T-Mobile US in Q3 2021, an estimated $4.21M increase.
- Calamos Wealth Management's biggest Q3 2021 reduction was Micron Technology, cutting an estimated $5.75M.
- Calamos Wealth Management fully exited Exact Sciences in Q3 2021, selling an estimated $3.61M.
- Calamos Wealth Management's ten largest holdings make up 39% of its $1.24B portfolio in Q3 2021.
- Calamos Wealth Management opened 6 new positions and closed 14 in Q3 2021.
- Calamos Wealth Management's portfolio value fell 3.6% quarter-over-quarter to $1.24B.
Based on Calamos Wealth Management's 13F filing for Q3 2021, filed 26 Oct 2021.